Estimating the Cumulative Incidence of SARS-CoV-2 Infection and the Infection Fatality Ratio in Light of Waning Antibodies

Mostrar otras versiones (1)

Serology tests can identify previous infections and facilitate estimation of the number of total infections. However, immunoglobulins targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been reported to wane below the detectable level of serologic assays (which is not necessa...

Descripción completa

Detalles Bibliográficos
Autores principales: Shioda, Kayoko, Lau, Max S.Y., Kraay, Alicia N.M., Nelson, Kristin N., Siegler, Aaron J., Sullivan, Patrick S., Collins, Matthew H., Weitz, Joshua S., Lopman, Benjamin A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162228/
https://www.ncbi.nlm.nih.gov/pubmed/33935138
http://dx.doi.org/10.1097/EDE.0000000000001361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162228/
https://www.ncbi.nlm.nih.gov/pubmed/33935138
http://dx.doi.org/10.1097/EDE.0000000000001361

Ejemplares similares